Wellington Management Group’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Buy |
132,900
+6,632
| +5% | +$75K | ﹤0.01% | 1633 |
|
|
2025
Q1 | $1.46M | Buy |
126,268
+3,405
| +3% | +$39.3K | ﹤0.01% | 1621 |
|
|
2024
Q4 | $1.04M | Buy |
122,863
+4,940
| +4% | +$41.8K | ﹤0.01% | 1695 |
|
|
2024
Q3 | $1.37M | Buy |
117,923
+33,900
| +40% | +$393K | ﹤0.01% | 1642 |
|
|
2024
Q2 | $990K | Buy |
84,023
+4,658
| +6% | +$54.9K | ﹤0.01% | 1672 |
|
|
2024
Q1 | $941K | Buy |
+79,365
| New | +$941K | ﹤0.01% | 1695 |
|
|
2022
Q4 | – | Sell |
-776,510
| Closed | -$11.3M | – | 2052 |
|
|
2022
Q3 | $11.3M | Buy |
776,510
+306,377
| +65% | +$4.45M | ﹤0.01% | 1075 |
|
|
2022
Q2 | $4.63M | Sell |
470,133
-876,609
| -65% | -$8.63M | ﹤0.01% | 1350 |
|
|
2022
Q1 | $19.9M | Sell |
1,346,742
-464,763
| -26% | -$6.85M | ﹤0.01% | 1019 |
|
|
2021
Q4 | $24M | Sell |
1,811,505
-19,936
| -1% | -$264K | ﹤0.01% | 1038 |
|
|
2021
Q3 | $32M | Buy |
1,831,441
+36,923
| +2% | +$644K | 0.01% | 950 |
|
|
2021
Q2 | $43M | Buy |
1,794,518
+285,493
| +19% | +$6.84M | 0.01% | 869 |
|
|
2021
Q1 | $38.8M | Buy |
1,509,025
+636,369
| +73% | +$16.3M | 0.01% | 886 |
|
|
2020
Q4 | $16.6M | Buy |
872,656
+108,697
| +14% | +$2.06M | ﹤0.01% | 1079 |
|
|
2020
Q3 | $9.62M | Buy |
763,959
+561,000
| +276% | +$7.06M | ﹤0.01% | 1111 |
|
|
2020
Q2 | $2.46M | Buy |
202,959
+3,644
| +2% | +$44.1K | ﹤0.01% | 1322 |
|
|
2020
Q1 | $1.53M | Sell |
199,315
-17,773
| -8% | -$136K | ﹤0.01% | 1418 |
|
|
2019
Q4 | $3.87M | Buy |
217,088
+191,019
| +733% | +$3.4M | ﹤0.01% | 1386 |
|
|
2019
Q3 | $303K | Buy |
+26,069
| New | +$303K | ﹤0.01% | 1949 |
|